Skip to main content
FinSpry Logo
FinSpry
IOVA logo
IOVA
(NASDAQ)
Iovance Biotherapeutics, Inc.
$7.10-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Iovance Biotherapeutics (IOVA) Stock Price & Financial Analysis

Iovance Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.70 - $7.25
52-Week High$6.92
52-Week Low$1.76
Open$6.84
Volume14.76M
Average Volume (3M)18.09M
Market Cap2.92B
Shares Outstanding418.51M
Price to Sales (P/S)9.29
Price to Book (P/B)0.74
EV/EBITDA-7.79
Revenue (TTM)285.61M
Net Income (TTM)-353.86M
Free Cash Flow (TTM)-305.02M
EPS (TTM)$-0.93
Profit Margin-123.90%
Operating Margin-127.16%
Return on Equity (ROE)-9.89%
Debt to Equity0.01
50-Day MA$4.45
200-Day MA$3.39
52-Week Change200.47%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Iovance Biotherapeutics

What is the current stock price for IOVA?

As of the latest trading session, IOVA stock trades at $7.10. The 52-week range is $1.76–$6.92, with a day range of $6.70–$7.25.

What is the P/E ratio for IOVA?

The P/E ratio (Price-to-Earnings) for IOVA is shown in the Key Statistics section. This valuation metric helps compare Iovance Biotherapeutics, Inc. to industry peers.

Does IOVA pay dividends?

Iovance Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IOVA?

Based on 3 analysts, the consensus for IOVA is Buy.

What is the market cap of IOVA?

Iovance Biotherapeutics's market capitalization is $2.97B, classifying it as a mid-cap company. Iovance Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.